scholarly journals Epidermoid carcinoma of the skin mimicking breast cancer

2013 ◽  
Vol 88 (2) ◽  
pp. 250-252 ◽  
Author(s):  
Baltasar Melo Neto ◽  
Giuliano da Paz Oliveira ◽  
Sabas Carlos Vieira ◽  
Livio Rodrigues Leal ◽  
José Andrade de Carvalho Melo Junior ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Skin Cancer ◽  
Head And Neck ◽  
Clinical Examination ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Histopathological Examination ◽  
Cell Cancer ◽  
Epidermoid Carcinoma ◽  
The World

Nonmelanoma skin cancer is the most frequent cancer in the world. Squamous cell cancer often occurs in sun-exposed areas, such as the head and neck. When it involves the breast and ulce-rates, invading the glandular parenchyma, it may mimic breast cancer. Confirmation by means of histopathological examination, combined with clinical examination, is a critical instrument for the accuracy of the diagnosis. We report a case of an epidermoid carcinoma located on the breast skin, initially diagnosed as breast cancer.

scholarly journals Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia

2016 ◽  
Vol 9 (2) ◽  
pp. 373-378 ◽  
Author(s):  
K.S. Schwab ◽  
A. Heine ◽  
T. Weimann ◽  
G. Kristiansen ◽  
P. Brossart
Keyword(s):  
Skin Cancer ◽  
Head And Neck ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Treated Patient ◽  
Cell Cancer ◽  
Death Receptor ◽  
Initial Therapy ◽  
Squamous Cancer ◽  
Hemolytic Crisis

Management of patients with metastatic squamous cell skin cancer, refractory to initial therapy with standard chemotherapy and radiation protocols, remains difficult with poor overall prognosis and limited therapeutic options. Recently, promising response rates with nivolumab, a programmed death receptor-1-blocking antibody, in squamous cancer of the head and neck have been demonstrated. Considering the similar histological patterns of squamous cell cancer of the skin and squamous cell cancer of the head and neck, we assumed that nivolumab could also be effective in our patients with refractory metastatic squamous cell cancer of the skin. So far, there have been no clinical data on the therapeutic efficacy of nivolumab in squamous cell skin cancer. We here present a case of a patient with metastatic squamous cell skin cancer refractory to previous therapies, who showed a good response to nivolumab over a period of 5 months, but developed a serious hemolytic crisis under nivolumab treatment after eight applications.

scholarly journals Emerging strategies for the early detection and prevention of head and neck squamous cell cancer

2011 ◽  
Vol 227 (2) ◽  
pp. 467-473 ◽  
Author(s):  
Santanu Dasgupta ◽  
Rupesh Dash ◽  
Swadesh K. Das ◽  
Devanand Sarkar ◽  
Paul B. Fisher
Keyword(s):  
Early Detection ◽  
Head And Neck ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Early Detection And Prevention ◽  
Neck Squamous Cell Cancer

scholarly journals Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer

2013 ◽  
Vol 34 (8) ◽  
pp. 1632-1636 ◽  
Author(s):  
M. McDermott ◽  
M. Hughes ◽  
T. Rath ◽  
J.T. Johnson ◽  
D.E. Heron ◽  
...  
Keyword(s):  
Head And Neck ◽  
Negative Predictive Value ◽  
Squamous Cell ◽  
Predictive Value ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Pet Ct ◽  
Neck Squamous Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document